International Stem Cell Corporation (ISCO)
OTCMKTS · Delayed Price · Currency is USD
0.1500
0.00 (0.00%)
Oct 23, 2025, 8:00 PM EDT
International Stem Cell Revenue
International Stem Cell had revenue of $2.45M in the quarter ending June 30, 2025, with 4.98% growth. This brings the company's revenue in the last twelve months to $9.20M, up 10.56% year-over-year. In the year 2024, International Stem Cell had annual revenue of $9.09M with 16.64% growth.
Revenue (ttm)
9.20M
Revenue Growth
+10.56%
P/S Ratio
0.13
Revenue / Employee
287.53K
Employees
32
Market Cap
1.17M
Revenue Chart
Revenue History
| Fiscal Year End | Revenue | Change | Growth |
|---|---|---|---|
| Dec 31, 2024 | 9.09M | 1.30M | 16.64% |
| Dec 31, 2023 | 7.79M | -391.00K | -4.78% |
| Dec 31, 2022 | 8.18M | 1.00M | 13.99% |
| Dec 31, 2021 | 7.18M | 48.00K | 0.67% |
| Dec 31, 2020 | 7.13M | -2.34M | -24.75% |
| Dec 31, 2019 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2018 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2017 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2016 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2015 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
Revenue Definition
Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.
Full DefinitionRelated Stocks
| Company Name | Revenue |
|---|---|
| American Oncology Network | 1.76B |
| Veradigm | 588.02M |
| Jushi Holdings | 256.36M |
| Glass House Brands | 221.55M |
| Elite Pharmaceuticals | 105.45M |
| Silence Therapeutics | 27.17M |
| QT Imaging Holdings | 8.26M |
| Northwest Biotherapeutics | 1.09M |
International Stem Cell News
- 7 months ago - International Stem Cell GAAP EPS of -$0.03, revenue of $9.09M - Seeking Alpha
- 7 months ago - International Stem Cell Corporation Announces 2024 Fourth Quarter and Year-End Results - Accesswire
- 2 years ago - Eighteenth edition of Fujio Cup Quiz won by Kasturba Medical College, India in the NCRM NICHE 2023 international stem cell meeting. - Business Wire
- 3 years ago - International Stem Cell Corporation Announces Strong Financial Results for the Quarter Ended March 31, 2022 - Accesswire